CIM
CELG

Chiron Investment Management’s Celgene Corp CELG Stock Holding History

Chiron Investment Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-165,516
Closed -$24.1M – 65
2017
Q3 		$24.1M Buy
165,516
+33,716
+26% +$4.59M 5.08% 4
2017
Q2 		$17.1M Buy
131,800
+36,600
+38% +$4.48M 5.08% 6
2017
Q1 		$11.8M Buy
+95,200
New +$11.4M 4.51% 6

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Chiron Investment Management's CELG Position: Q4 2017 in Review

Chiron Investment Management sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 165,516 shares — an estimated $24.1M sold.

Chiron Investment Management first reported a position in CELG in Q1 2017 and held it in 3 quarters. The position peaked at $24.1M in Q3 2017. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Chiron Investment Management reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Chiron Investment Management sold 165,516 Celgene Corp shares in Q4 2017, an estimated $24.1M.
  • Chiron Investment Management first reported a position in Celgene Corp in Q1 2017 and held it in 3 quarters.
  • Chiron Investment Management's Celgene Corp position peaked at $24.1M in Q3 2017.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Chiron Investment Management's 13F filing for Q4 2017, filed 9 Feb 2018.